Abstract
Several recent studies have shown that a subset of patients with metastatic cancer in limited organs may benefit from metastasis-directed therapy. We present a series on patients treated with hypofractionated image-guided helical tomotherapy (HT), and assess the efficacy and toxicity of this new technology in the treatment of extracranial oligometastasis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: International Journal of Radiation Oncology*Biology*Physics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.